Investigating the IFN landscape in mild and severe COVID-19 cases it was revealed that IFNλ1 and IFNλ3 are dominant in the upper airways of mild COVID-19 patients and are responsible for the expression of protective ISGs. The gene discussed is IFNA1; the disease is COVID-19.